INS and hepatocellular carcinoma: The epidemiology of obesity-associated HCC (65) and in vitro and in vivo experiments suggest that an obesogenic lifestyle, via pro-inflammatory cytokines, insulin resistance, steatosis, and lipotoxicity, may progress from metabolic syndrome to NASH (6) and HCC (65).